United Bank Takes $2.28 Million Position in Cencora, Inc. $COR

Posted by Francis Steltz on Aug 20th, 2026

United Bank acquired a new position in shares of Cencora, Inc. (NYSE:COR – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 8,048 shares of the company’s stock, valued at approximately $2,277,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Shepherd Financial Partners LLC acquired a new stake in shares of Cencora during the second quarter worth $1,576,000. Johnson Financial Group Inc. acquired a new position in Cencora in the 2nd quarter worth $177,000. West Family Investments Inc. acquired a new position in Cencora in the 2nd quarter worth $794,000. NewEdge Wealth LLC bought a new position in Cencora during the 2nd quarter worth about $671,000. Finally, Great Lakes Advisors LLC bought a new position in Cencora during the 2nd quarter worth about $5,102,000. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Lauren M. Tyler purchased 550 shares of the firm’s stock in a transaction on Monday, June 22nd. The stock was purchased at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the purchase, the director directly owned 4,359 shares in the company, valued at $1,177,932.57. This trade represents a 14.44% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.38% of the stock is currently owned by corporate insiders.

Cencora Stock Up 0.2%

Shares of COR stock opened at $316.78 on Thursday. The firm’s fifty day moving average price is $301.20 and its two-hundred day moving average price is $312.16. The company has a current ratio of 0.93, a quick ratio of 0.58 and a debt-to-equity ratio of 3.53. Cencora, Inc. has a 1 year low of $244.82 and a 1 year high of $377.54. The firm has a market capitalization of $60.45 billion, a P/E ratio of 23.53, a PEG ratio of 1.81 and a beta of 0.57.

Cencora (NYSE:COR – Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 EPS for the quarter, topping analysts’ consensus estimates of $4.35 by $0.13. The company had revenue of $84.75 billion during the quarter, compared to the consensus estimate of $84.31 billion. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The company’s quarterly revenue was up 5.1% on a year-over-year basis. During the same period in the prior year, the business posted $4.00 EPS. On average, equities analysts predict that Cencora, Inc. will post 17.87 EPS for the current fiscal year.

Cencora announced that its board has approved a stock repurchase plan on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the company to reacquire up to 3.9% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s management believes its stock is undervalued.

Cencora Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be given a dividend of $0.60 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $2.40 annualized dividend and a yield of 0.8%. Cencora’s dividend payout ratio is 17.83%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Robert W. Baird set a $370.00 price target on Cencora in a report on Thursday, August 6th. Barclays decreased their price objective on Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, June 10th. Citigroup reissued a “buy” rating on shares of Cencora in a research report on Thursday, August 6th. Wells Fargo & Company boosted their target price on Cencora from $331.00 to $395.00 and gave the company an “overweight” rating in a research note on Tuesday, August 11th. Finally, Morgan Stanley upped their price target on Cencora from $342.00 to $346.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $370.85.

View Our Latest Research Report on Cencora

About Cencora

(Free Report)

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.